ClinicalTrials.gg
RecruitingNCT06726239Updated Jul 1, 2025

Progressive Relaxation Exercises Before Mobilization:Effects on Pain, Anxiety and Physiologic Parameters CABG Patients

An interventional study of Progressive relaxation exercises in Pain, Anxiety and Physiological Parameter, sponsored by Istanbul University - Cerrahpasa. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 35 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-07-01.

Sponsored by Istanbul University - Cerrahpasa · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Registered 6 months after the study started (first participant enrolled May 2024, registered Dec 2024).
  • Started May 2024; still recruiting 2 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
68
Allocation
Randomized
Ages
35 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 54 studies in Pain by Istanbul University - Cerrahpasa — 13 open to participants now, 14 under way, none of them phase 3. Pain · Istanbul University - Cerrahpasa.

Planned enrollment
29th of 51
68 · median 80
Started
2024
with 10 others
No phase
50 of 54
10 open now
Primary completion
2025-06
later than 6 of 13 live
Registered
39th of 54
by date

Among the 54 studies in Pain by Istanbul University - Cerrahpasa, this one is the 29th largest by planned enrollment of the 51 interventional ones that give a count, is one of 11 that started in 2024, is one of 50 with no phase, reaches primary completion later than 6 of the 13 other live ones, and was the 39th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

13 of the 54 studies in Pain by Istanbul University - Cerrahpasa are open now, in 1 country. Recruiting first, the newest first:

7 more — sign in →

By country, each count listing its studies:

All 13 open studies →

Where they have run

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 35 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 54 studies in Pain by Istanbul University - Cerrahpasa, or all of them as a file.
02

Study summary

This study is planned as a randomized controlled experimental study to determine the effect of progressive relaxation exercises applied before mobilization on pain, anxiety and physiological parameters in patients undergoing coronary artery bypass graft surgery.

Read the detailed description

This study was planned as a randomized controlled experimental study to determine the effect of progressive relaxation exercises on pain, anxiety and physiological parameters before mobilization in patients undergoing coronary artery bypass graft (CABG) surgery. Ethics committee and institutional approval were obtained before starting the study. Patients were informed about the study and their verbal and written informed consent was obtained. The study will be conducted in a public hospital in Istanbul with 68 patients (experimental group = 34, control group = 34) who met the research criteria and underwent CABG surgery. The patients in the experimental group will be given progressive relaxation exercises twice at 6-hour intervals on postoperative day 1 and day 2. Patients in the control group will receive routine treatment and care. Physiological parameters, pain, and anxiety levels will be evaluated twice daily on postoperative days 1 and 2 in both groups.It was also stated that a smart wristband should be worn on the arms of the patients on postoperative days 1 and 2 to monitor the frequency of mobilization in both the experimental and control groups. In addition, the frequency of analgesic use will be monitored.

03

Conditions studied

  • Pain
  • Anxiety
  • Physiological Parameter
  • Mobilization
  • Coronary Artery Bypass Graft Surgery (CABG)
  • PROGRESSIVE MUSCLE RELAXATION EXERCISES

Keywords

  • coronary artery bypass graft surgery
  • pain
  • Anxiety
  • progressive relaxation exercise
  • physiological parameter
04

Who can participate

Ages eligible
35 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ability to read and write in Turkish,
  • Analgesics given ≥4h before assessment,
  • Conscious and communicative,
  • Elective coronary artery bypass graft surgery planned,
  • Patients undergoing coronary artery bypass graft surgery for the first time were included in the study.

Exclusion criteria

Exclusion Criteria:

  • Diagnosed with a psychiatric or neurological disorder,
  • Diagnosis of a musculoskeletal condition that could affect mobilization,
  • Patients with hearing and vision loss,
  • Patients participating in another clinical trial during the same period,
  • Patients who developed any complications during the postoperative period were excluded.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
68 participants (estimated)

Study arms

  • No intervention
    No Intervention

    In the preoperative period, patients in the control group completed the Patient Demographic Information Form and the Trait Anxiety Inventory. Patients were preoperatively informed about wearing a smart bracelet on postoperative days 1 and 2 to track step count and walking distance. Physiological parameters, state anxiety, and pain levels (Short-Form McGill Pain Questionnaire) were evaluated at pre-test, 30 minutes later, and 15 minutes after mobilization. Additionally, pain intensity was assessed immediately after mobilization. On postoperative days 1 and 2, all assessments were conducted twice daily. The frequency of analgesic administration was also monitored.

  • Experimental
    Experimental

    In the preoperative period, patients completed the Patient Demographic Information Form and the Trait Anxiety Inventory. Patients were preoperatively informed about wearing a smart bracelet on postoperative days 1 and 2 to track step count and walking distance. Furthermore, patients in the intervention group received video-assisted training on diaphragmatic breathing and progressive muscle relaxation (PMR) exercises. In the intervention group, PMR was performed twice a day on postoperative days 1 and 2. Physiological parameters, state anxiety, and pain levels (Short-Form McGill Pain Questionnaire) were measured at pre-test, 5 minutes after each PMR session, and 15 minutes after mobilization. Additionally, pain intensity was assessed immediately after mobilization. The frequency of analgesic administration was also monitored.

    Other: Progressive relaxation exercises

Interventions

  • OtherProgressive relaxation exercises

    The aim of relaxation exercises is to help individuals recognize the difference between tension and relaxation and to enable them to relax in situations of stress. These exercises are performed with light background music and verbal instructions, allowing patients to mentally focus on the process. The progressive relaxation technique involves the voluntary contraction and subsequent relaxation of muscle groups, typically starting from the hands and progressing to the feet, with each muscle group activated in sequence. During the exercise, the instructions and steps from the 'Relaxation Exercises' CD published by the Turkish Psychologists Association will be followed.

06

What researchers measure

Primary outcomes

  1. Descriptive Characteristics Form

    The first part includes questions about demographic characteristics such as gender, age, body mass index (height-weight), marital status, education level, income level and occupation, and the second part includes questions about other chronic diseases, previous surgery, previous stay in the intensive care unit, smoking and alcohol use.

    Time frame: Preoperative

  2. Trait Anxiety Inventory

    The Trait Anxiety Inventory is used to determine how the individual "usually" feels and the items of the scale are scored between 1-4 points (1=almost never, 2=sometimes, 3=very often, 4=almost always). There are 7 reversed statements in the trait anxiety subscale (items 21, 26, 27, 30, 33, 36 and 39).

    Time frame: Preoperative

  3. Physiological parameters monitoring

    Physiological parameters will be monitored.

    Time frame: Postoperative Day 1:(measured twice, 6-hour apart): Control: Pre-test, 30 min later, 15 min post-mobilization Experimental: Pre-test, 5 min post-PGE, 15 min post-mobilization. Postoperative Day 2: Both groups:Same measurements at 6-hour intervals, twice

  4. State Anxiety Inventory

    It is used to determine how the individual feels "right now" and the items of the scale are scored between 1-4 points (1=not at all, 2=somewhat, 3=very much, 4=completely).

    Time frame: Postop Day 1:(measured twice, 6-hour apart): Control: Pre-test,30 minutes after,15 min post-mobilization.Experimental: Pre-test, 5 minutes after PGE, 15 min post-mobilization.Postoperative Day 2: Both groups:Same measurements at 6-hour intervals, twice

  5. Short Form McGill Pain Questionnaire

    The scale consists of three parts in which the nature of pain, intensity of pain and overall pain intensity are evaluated.

    Time frame: Postop1:Measured twice at 6h:Control:Pre-test, 30 min later, post-mobilization vas, 15 min post-mobilization. Experimental: Pre-test, 5 min post-PGE, post-mobilization vas, 15 min post-mobilization.Postop2: Both groups:Measured twice at 6-hour intervals

Secondary outcomes

  1. Mobilization Schedule

    Mobilization will be assessed on postoperative days 1 and 2 based on the number of steps taken, distance covered, and relevant features of the mobilization process.

    Time frame: Postoperative day 1 and 2

  2. Analgesia monitoring form

    In this form prepared by the researcher in line with the literature, the name, dose, time and route of administration will be recorded in case of analgesic use of the patients.

    Time frame: Postoperative day 1 and 2

07

Study locations

1 of 1 sites recruiting
  • Kartal Koşuyolu Yüksek İhtisas Eğitim ve Araştırma Hastanesi
    Istanbul, Istanbul 34320, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared because the ethical approval for the study and the informed consent obtained from participants do not include permission to share data with third parties. Additionally, the responsibility to protect participant privacy and data confidentiality prevents such sharing.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for Jun 2025, 12 months after the start.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 12 months is above that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 2, 2024
First posted
Dec 10, 2024
StartActual
May 31, 2024
Primary completionEst.
Jun 30, 2025
CompletionEst.
Jun 30, 2025
Last update
Jul 1, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06726239
Responsible party
Tugce Bozkurt Elmas (PhD Candidate in Surgical Nursing, Istanbul University-Cerrahpasa, Istanbul University - Cerrahpasa) — Principal investigator
First posted
Dec 10, 2024
Start date
May 31, 2024
Primary completion
Jun 30, 2025 (estimated)
Completion
Jun 30, 2025 (estimated)
Last update
Jul 1, 2025

Study contacts

Tuğçe Bozkurt
Contact
tgcebzkrt55@gmail.com
05063137927
Ayfer Özbaş
Contact
tgcebzkrt55@gmail.com
05063137927

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion